|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01219101 |
|
Date of registration:
|
09/10/2010 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination
|
|
Scientific title:
|
Evaluate the Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination |
|
Date of first enrolment:
|
March 2011 |
|
Target sample size:
|
95 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01219101 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Iran, Islamic Republic of
| | | | | | | |
|
Contacts
|
|
Name:
|
hamid gourabi, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
President of Royan Institute |
|
|
Name:
|
Ashraf Moieni, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Scientific Board |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- The patients with first treatment cycle
- Age between 25 and 30 years,
- Infertility for at least 2 years' duration,
- Oligomenorrhea or amenorrhea associated with a positive Progesterone challenge test
- Women with normal concentrations of prolactin, free thyroxin and thyroid-stimulating
hormone (TSH)
Exclusion Criteria:
- Women whose partners had an abnormal semen analysis according to World Health
Organization
- Women who had uterine or tubal abnormalities on hysterosalpingography, and women who
had a body mass index of >30 kg/m2.
Age minimum:
25 Years
Age maximum:
30 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Infertility
|
|
Intervention(s)
|
|
Drug: clomiphene citrate with plasebo
|
|
Drug: clomiphene citrate with ethinyl esteradiol
|
|
Primary Outcome(s)
|
|
Clinical Pregnancy rate
[Time Frame: 4-6 weeks after embryos transfer(ET)]
|
|
Secondary Outcome(s)
|
|
Duration of stimulation days
[Time Frame: 5 days]
|
|
Endometrial thickness
[Time Frame: 13 days]
|
|
Secondary ID(s)
|
|
Royan-Emb-010
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|